Bodin Alexandre, Bisson Arnaud, Andre Clémentine, Babuty Dominique, Clementy Nicolas
Service de Cardiologie, Centre Hospitalier Universitaire Trousseau et EA7505, Faculté de Médecine, Université François Rabelais, 37000 Tours, France.
J Clin Med. 2021 Dec 15;10(24):5886. doi: 10.3390/jcm10245886.
Up to 40% of patients are CRT non-responders. Multisite pacing, using a unique quadripolar lead, also called multipoint/multipole pacing (MPP), is a potential alternative. We sought to determine the feasibility of intentional anodal capture using a single LV quadripolar lead, to reproduce MPP without the need of a specific algorithm (so-called "pseudo MPP").
Consecutive patients implanted with a commercially available CRT device and a quadripolar LV lead in our department were prospectively included. The electric charge (Q, in Coulomb) of RV and LV pacing spikes were calculated for all available LV pacing configurations at the threshold. The best MPP was defined as the configuration with the lowest consumption (Q + Q + Q). The best "pseudo MPP" (Q + Q) and best BVp (Q + Q) were also calculated. A theoretical longevity was estimated for each configuration at the threshold without a safety margin.
A total of 235 configurations were tested in 15 consecutive patients. "Pseudo-MPP" was feasible in 80% of patients with 3.1 ± 2.6 vectors available per-patient and LV-LV (most distant electrodes) vectors were available in 47% of patients. Each MPP pacing spike electrical charge was comparable to "pseudo-MPP" (18,428 ± 6863 µC and 20,528 ± 5509 µC, respectively, = 0.15). Theoretical longevity was 6.2 years for MPP, 5.6 years for "pseudo-MPP" and 13.7 years for BVp.
"Pseudo MPP" using intentional anodal capture with a quadripolar left ventricular lead, mimicking conventional multisite pacing, is feasible in most of CRT patients, with comparable energy consumption. Further studies on their potential clinical impact are needed.
高达40%的患者对心脏再同步治疗(CRT)无反应。使用独特的四极导线进行多部位起搏,也称为多点/多极起搏(MPP),是一种潜在的替代方法。我们试图确定使用单个左心室四极导线进行有意阳极夺获的可行性,以在无需特定算法的情况下重现MPP(所谓的“伪MPP”)。
前瞻性纳入在我们科室植入市售CRT设备和四极左心室导线的连续患者。计算阈值时所有可用左心室起搏配置下右心室和左心室起搏尖峰的电荷(Q,单位为库仑)。最佳MPP定义为功耗最低的配置(Q+Q+Q)。还计算了最佳“伪MPP”(Q+Q)和最佳双心室起搏(BVp)(Q+Q)。在无安全裕度的情况下,估计每种配置在阈值时的理论使用寿命。
连续15例患者共测试了235种配置。80%的患者可行“伪MPP”,每位患者有3.1±2.6个可用向量,47%的患者有左心室-左心室(最远电极)向量。每个MPP起搏尖峰电荷与“伪MPP”相当(分别为18428±6863µC和20528±5509µC,P=0.15)。MPP的理论使用寿命为6.2年,“伪MPP”为5.6年,BVp为13.7年。
使用四极左心室导线进行有意阳极夺获模拟传统多部位起搏的“伪MPP”在大多数CRT患者中可行,且能量消耗相当。需要进一步研究其潜在的临床影响。